A detailed history of Lighthouse Investment Partners, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Lighthouse Investment Partners, LLC holds 34,564 shares of EXEL stock, worth $776,653. This represents 0.04% of its overall portfolio holdings.

Number of Shares
34,564
Previous 123,853 72.09%
Holding current value
$776,653
Previous $2.97 Million 72.4%
% of portfolio
0.04%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$20.17 - $23.93 $1.8 Million - $2.14 Million
-89,289 Reduced 72.09%
34,564 $820,000
Q4 2023

Feb 14, 2024

BUY
$19.25 - $24.13 $2.38 Million - $2.99 Million
123,853 New
123,853 $2.97 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $7.23B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Lighthouse Investment Partners, LLC Portfolio

Follow Lighthouse Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lighthouse Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lighthouse Investment Partners, LLC with notifications on news.